Professor, The Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases,
The Feinstein Institute for Medical Research
Professor, Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Phone: (516) 562-2901
Dr. Santiago-Schwarz is a professor at the Feinstein Institute for Medical Research and professor of Molecular Medicine at Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. She was born in San Juan, Puerto Rico and attended the University of Puerto Rico (UPR) where she was first introduced to, and connected with, the field of immunology. After obtaining a BS in biology from the UPR, she pursued a MS in Biology/Immunology from New York University (NYU) while working under the mentorship of Dr. Joel Buxbaum, Chief of Rheumatology at NYU. From there, Dr. Santiago-Schwarz went on to pursue doctoral studies at the University of Southern California, School of Medicine, under the guidance of Drs. Jeffrey Frelinger and Richard O’Brien. Her thesis work described for the first time, isolating and functionally characterizing human dendritic cells (DCs) from peripheral blood. Subsequent work related to further understanding of DC biology in humans included the initial delineation of cytokine-driven human DC hematopoiesis from cord blood progenitors, deciphering key molecular events related to the positive and negative control of DC development and function, the first description of a leukemic counterpart of myeloid DCs.
At the Feinstein Institute for Medical Research, Dr. Frances Santiago-Schwarz’ research continues to be concerned with control of monocyte and DC development in normal and abnormal physiology and developing new therapeutic agents for autoimmune diseases.
Throughout her career, Dr. Santiago-Schwarz has also been actively engaged in the direct training of biomedical research/physician scientists at distinct levels of training and enhancing educational experiences for underrepresented groups in STEM.
Current work includes disrupted cytokine and inhibitory immunoreceptor networks (LAIR-1, CD33) affecting monocyte/DC activity, particularly in rheumatoid arthritis and systemic lupus erythematosus. A key collaboration with Drs. Betty Diamond and Myoungsun Son stems from our discovery that C1q interactions with the inhibitory receptor LAIR-1 control dendritic cell activation, differentiation and function. Examples of ongoing and developing projects include: deciphering the biology of inhibitory immunoreceptor CD33 (Siglec-3) and CD305 (LAIR-1) within the monocyte and dendritic cell lineages; understanding how autophagy regulates monocyte and dendritic cell development; and developing strategies employing extracellular vesicles for the treatment of autoimmune disease.
University of Puerto Rico, Rio Piedras, Puerto Rico
Field of Study: Biology
New York University, NY, NY
Field of Study: Biology/Immunology
University of Southern California, LA, CA
Field of Study: Molecular Biology & Immunology
New York University, NY, NY
Field of Study: Molecular Biology
State University of New York, Stony Brook, NY
Field of Study: Immunology
1997 Runner up Dolph Adams Award for most highly cited original research article (1997)
2005 SUNY Chancellor’s Award for Excellence in Research (2005)
2008 Farmingdale State College Foundation award for Excellence in Teaching
2008, 2014 Mentoring Awards from College Science Technology Enhancing Program (C-STEP)
2011 CARES-“Commendation and Recognition for Exceptional Service” Award
2014 Mentoring award from Advancing Women in Science and Medicine (AWSM)
2015 Mentoring award from Advancing Women in Science and Medicine (AWSM)